Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Policy Tracker

Full Bill Tracker

Every tracked proposal: pending, failed, superseded, stalled and enacted — across psychedelics, cannabis, kratom and 7-OH.

Denmark

Bills tracked for this country and its states or regions.

1 of 1 tracked bills · newest recorded action first

  • Denmark · Psychedelics
    Did not pass; died when the session ended
    B 5

    Motion for parliamentary resolution on establishing a working group on the potential of psychedelic substances from a public health perspective [Forslag til folketingsbeslutning om at nedsætte en arbejdsgruppe om psykedeliske stoffers potentiale i folkesundhedsperspektiv] (2025-26 (1st session))

    1. IntroducedOct 8, 2025 (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    No dated action recorded

    The proposal lapsed after first reading and referral to committee.

    Bill source (opens in a new tab)